Inventor · disambiguated record
Richard W. Childs
Also filed as: CHILDS RICHARD W · CHILDS RICHARD WILLIAM · CHILDS RICHARD WILLIAM WYATT
12 granted patents·8 pending applications·27 citations·filing 2005–2025
87Inventor score
Files withUS HEALTH13CHILDS RICHARD WILLIAM WYATT3CHILDS RICHARD W1THE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES1THE US SECRETARY DEPARTMENT OF HEALTH1
Top patents by PatentIndex Score
20 records- 0185US11293010B2Methods of producing modified natural killer cells and methods of useUS HEALTH·Filed 2017·Granted Apr 5, 2022·4 cites·21 claims
- 0284US10813952B2NK cells with an increased antibody-dependent cellular toxicity (ADCC) against tumorsTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2015·Granted Oct 27, 2020·4 cites·6 claims
- 0384US8790597B2Selective access to cryopreserved samplesCHILDS RICHARD W·Filed 2010·Granted Jul 29, 2014·9 cites·20 claims
- 0483US9296500B2Selective access to cryopreserved samplesUS HEALTH·Filed 2014·Granted Mar 29, 2016·3 cites·12 claims
- 0576US10214726B2Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subjectUS HEALTH·Filed 2017·Granted Feb 26, 2019·1 cites·11 claims
- 0674US8921050B2Methods of diagnosing renal cell carcinomaCHILDS RICHARD WILLIAM WYATT·Filed 2007·Granted Dec 30, 2014·3 cites·2 claims
- 0770US10106620B2Blocking CD38 using anti-CD38 F(ab′)2 to protect NK cellsUS HEALTH·Filed 2015·Granted Oct 23, 2018·3 cites·27 claims
- 0869US2024238339A1Nk cells or t cells expressing hematopoietic growth factor receptors and methods of useUS HEALTH·Filed 2024·Application pending·0 cites
- 0968US12448604B2Methods of producing modified natural killer cells and methods of useUS HEALTH·Filed 2022·Granted Oct 21, 2025·0 cites·14 claims
- 1064US2023089654A1Nk cells or t cells expressing hematopoietic growth factor receptors and methods of useUS HEALTH·Filed 2022·Application pending·0 cites
- 1163US12188005B2NK cells with an increased antibody-dependent cellular toxicity (ADCC) against tumorsUS HEALTH·Filed 2020·Granted Jan 7, 2025·0 cites·14 claims
- 1263US10557118B2Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subjectTHE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2019·Granted Feb 11, 2020·0 cites·18 claims
- 1362US9856453B2Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subjectTHE US SECRETARY DEPARTMENT OF HEALTH·Filed 2014·Granted Jan 2, 2018·0 cites·8 claims
- 1461US2025136940A1Nk cells with an increased antibody-dependent cellular toxicity (adcc) against tumorsUS HEALTH·Filed 2025·Application pending·0 cites
- 1560US2024024479A1Nk cells or t cells expressing chimeric hematopoietic growth factor receptors and methods of useUS HEALTH·Filed 2023·Application pending·0 cites
- 1655US2024009236A1Modified nk cells with reduced ccr5 expression and methods of their useUS HEALTH·Filed 2021·Application pending·0 cites
- 1750US11779603B2HERV-E reactive T cell receptors and methods of useUS HEALTH·Filed 2017·Granted Oct 10, 2023·0 cites·6 claims
- 1842US2014086890A1Compositions and methods for treating hyperproliferative disordersCHILDS RICHARD WILLIAM WYATT·Filed 2013·Application pending·0 cites
- 1941US2016015893A1Direct pressure-mediated intra-bone delivery system for cellular therapeuticsUS HEALTH·Filed 2014·Application pending·0 cites
- 2041US2009104170A1Compositions and methods for treating hyperproliferative disordersCHILDS RICHARD WILLIAM WYATT·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Richard W. Childs files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →